Hepatology

Cuando el hígado habla y la ciencia escucha: del magnesio al ARN terapéutico | Malu Martínez Chantar

When the liver speaks and science listens: from magnesium to therapeutic RNA | Malu Martínez Chantar

Hepatitis B Markers Explained | HBsAg, Anti-HBs, Anti-HBc

Hepatitis E | Clinical Medicine

Hepatitis C | Clinical Medicine

Hepatitis B | Podcast

Hepatitis B | Clinical Medicine

Hepatitis A | Podcast

From signatures to systems: Multi-omics architecture of MASLD

Hepatitis ABC

REPLAY - Webinaire sur les Maladies Vasculaires du Foie

REPLAY - Webinar on Vascular Liver Diseases

LPAC : Physiopathologie, épidémiologie, diagnostic et traitement médical - JAMRF25

LPAC: Pathophysiology, Epidemiology, Diagnosis and Medical Treatment - JAMRF25

Groupes de Travail FILFOIE : Recherche – JAMRF25

FILFOIE Working Groups: Research – JAMRF25

Fil rouge FILFOIE : Hommage à Olivier Chazouillières – JAMRF25

FILFOIE's central theme: A tribute to Olivier Chazouillières – JAMRF25

When should PSVD be suspected - Paris PSVD Meeting

Surrogate markers of outcome in PSVD: do’s and don’ts - Paris PSVD Meeting

Specificities of PSVD in children and transition to adulthood - Paris PSVD Meeting

PSVD without portal hypertension - Paris PSVD Meeting

Prognostic and natural history of PSVD with signs of portal - Paris PSVD Meeting

Preclinical models of PSVD - Paris PSVD Meeting

Pathophysiology: is PSVD an immune, a vascular or a coagulation disorder? - Paris PSVD Meeting

Pathological changes in PSVD: current view and future directions – Paris PSVD Meeting

Novel therapies and therapeutic approaches - Paris PSVD Meeting

Nodules in PSVD - Paris PSVD Meeting

Management of portal hypertension complications in PSVD - Paris PSVD Meeting

Inclusion criteria for studies on PSVD - Paris PSVD Meeting

Imaging and PSVD: improving diagnosis and prognosis – Paris PSVD Meeting

Hemodynamic changes in PSVD and their modulation - Paris PSVD Meeting

Hard endpoints in PSVD studies - Paris PSVD Meeting

Conditions associated with PSVD: impact on prognosis and treatment – Paris PSVD Meeting

Can PSVD regress - Paris PSVD Meeting

Can PSVD lead to cirrhosis - Paris PSVD Meeting

Hepatitis C: A Tale of Two Organs

Table ronde – Single-cell omics et maladies rares du foie : échanges et perspectives – JR 2025

Round table – Single-cell omics and rare liver diseases: exchanges and perspectives – JR 2025

Table ronde – Sénescence cellulaire et maladies rares du foie : échanges et applications – JR 2025

Round table – Cellular senescence and rare liver diseases: exchanges and applications – JR 2025

Single-cell omics dans l’hépatite auto-immune – JR 2025

Single-cell omics in autoimmune hepatitis – JR 2025

Single-cell et maladie vasculaire porto-sinusoïdale – JR 2025

Single-cell and porto-sinusoidal vascular disease – JR 2025

Sénescence cellulaire et thérapies anti-sénescence dans la cirrhose biliaire pédiatrique – JR 2025

Cellular senescence and anti-senescence therapies in pediatric biliary cirrhosis – JR 2025

Comprendre la fibrose biliaire grâce au single-cell omics – JR 2025

Understanding biliary fibrosis using single-cell omics – JR 2025

Actualités du réseau MVF – JR 2025

MVF Network News – JR 2025

Reporting back from INHSU 2025